Massachusetts Financial Services
CAI

Massachusetts Financial Services’s Caris Life Sciences CAI Stock Holding History

Massachusetts Financial Services’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.79M Sell
267,950
-673,689
-72% -$14.7M ﹤0.01% 759
2025
Q4 		$25.4M Sell
941,639
-29,691
-3% -$836K 0.01% 604
2025
Q3 		$29.4M Sell
971,330
-78,398
-7% -$2.5M 0.01% 572
2025
Q2 		$28M Buy
+1,049,728
New +$28.3M 0.01% 566

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $326M AUM
SSP
Sixth Street Partners Dallas, Texas $711M AUM 9.3% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services's CAI Position: Q1 2026 in Review

Massachusetts Financial Services reduced its Caris Life Sciences (CAI) stake by 72% in Q1 2026, selling an estimated $14.7M and leaving 267,950 shares worth $4.79M. The position accounts for ﹤0.01% of the portfolio, ranked #759.

Massachusetts Financial Services first reported a position in CAI in Q2 2025 and has held it in 4 quarters since. The position peaked at $29.4M in Q3 2025. 202 funds tracked by Wall St. Rank hold CAI as of Q1 2026.

  • Massachusetts Financial Services held 267,950 shares of Caris Life Sciences worth $4.79M as of Q1 2026.
  • Massachusetts Financial Services sold 673,689 Caris Life Sciences shares in Q1 2026, an estimated $14.7M.
  • Caris Life Sciences made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q1 2026, its #759 holding.
  • Massachusetts Financial Services first reported a position in Caris Life Sciences in Q2 2025 and has held it in 4 quarters since.
  • Massachusetts Financial Services's Caris Life Sciences position peaked at $29.4M in Q3 2025.
  • 202 funds tracked by Wall St. Rank held Caris Life Sciences as of Q1 2026.

Based on Massachusetts Financial Services's 13F filing for Q1 2026, filed 14 May 2026.